title: Assessment of the Reporting Quality of Placebo-controlled Randomized Trials on the Treatment of Type 2 Diabetes With Traditional Chinese Medicine in Mainland China: A PRISMA-Compliant Systematic Review.
abstract: Placebo-controlled randomized trials are often used to evaluate the absolute effect of new treatments and are considered gold standard for clinical trials. No studies, however, have yet been conducted evaluating the reporting quality of placebo-controlled randomized trials. The current study aims to assess the reporting quality of placebo-controlled randomized trials on treatment of diabetes with Traditional Chinese Medicine (TCM) in Mainland China and to provide recommendations for improvements.China National Knowledge Infrastructure database, Wanfang database, China Biology Medicine database, and VIP database were searched for placebo-controlled randomized trials on treatment of diabetes with TCM. Review, animal experiment, and randomized controlled trials without placebo control were excluded. According to Consolidated Standards of Reporting Trials (CONSORT) 2010 checklists items, each item was given a yes or no depending on whether it was reported or not.A total of 68 articles were included. The reporting percentage in each article ranged from 24.3% to 73%, and 30.9% articles reported more than 50% of the items. Seven of the 37 items were reported more than 90% of the items, whereas 7 items were not mentioned at all. The average reporting for "title and abstract," "introduction," "methods," "results," "discussion," and "other information" was 43.4%, 78.7%, 40.1%, 49.9%, 71.1%, and 17.2%, respectively. The percentage of each section had increased after 2010. In addition, the reporting of multiple study centers, funding, placebo species, informed consent forms, and ethical approvals were 14.7%, 50%, 36.85%, 33.8%, and 4.4%, respectively.Although a scoring system was created according to the CONSORT 2010 checklist, it was not designed as an assessment tool. According to CONSORT 2010, the reporting quality of placebo-controlled randomized trials on the treatment of diabetes with TCM improved after 2010. Future improvements, however, are still needed, particularly in methods sections.
authors.affiliation: From the Department of Endocrinology, China Academy of Chinese Medical Sciences, Guang'anmen Hospital (XZ, ZZ, JG, RY, HC, FL, XT); Graduate School, Beijing University of Chinese Medicine, Beijing (XZ, RY); Department of Endocrinology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin (TZ); and Department of Endocrinology, Dongzhimen Hospital Eastern Affiliated to Beijing University of Chinese Medicine, Beijing, China (YG).
authors.forename: Xiyan
authors.initials: X
authors.lastname: Zhao
authors.forename: Zhong
authors.initials: Z
authors.lastname: Zhen
authors.forename: Jing
authors.initials: J
authors.lastname: Guo
authors.forename: Tianyu
authors.initials: T
authors.lastname: Zhao
authors.forename: Ru
authors.initials: R
authors.lastname: Ye
authors.forename: Yu
authors.initials: Y
authors.lastname: Guo
authors.forename: Hongdong
authors.initials: H
authors.lastname: Chen
authors.forename: Fengmei
authors.initials: F
authors.lastname: Lian
authors.forename: Xiaolin
authors.initials: X
authors.lastname: Tong
mesh_terms: D002681:China; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D008516:Medicine, Chinese Traditional / Q000379:methods / Q000592:standards; D016032:Randomized Controlled Trials as Topic / Q000379:methods / Q000592:standards*
chemical_list: D007004:Hypoglycemic Agents
references.citation: Diabetes Obes Metab. 2013 May;15(5):448-54
references.pmid: 23231379
references.citation: PLoS One. 2012;7(7):e38461
references.pmid: 22768291
references.citation: Am J Med. 2006 Sep;119(9):800.e1-11
references.pmid: 16945616
references.citation: Am J Chin Med. 2012;40(5):877-86
references.pmid: 22928822
references.citation: Ann Intern Med. 2004 Nov 16;141(10):781-8
references.pmid: 15545678
references.citation: Medicine (Baltimore). 2015 Jul;94(26):e1008
references.pmid: 26131801
references.citation: Evid Based Complement Alternat Med. 2013;2013:250690
references.pmid: 23956766
references.citation: Ann Intern Med. 2001 Apr 17;134(8):663-94
references.pmid: 11304107
references.citation: JAMA. 1996 Aug 28;276(8):637-9
references.pmid: 8773637
references.citation: J Clin Endocrinol Metab. 2014 Feb;99(2):648-55
references.pmid: 24432995
references.citation: Aust Vet J. 1996 Oct;74(4):311
references.pmid: 8937675
references.citation: PLoS One. 2014 Jan 28;9(1):e86360
references.pmid: 24489719
references.citation: Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 1989 Apr;11(2):87-91
references.pmid: 2528425
references.citation: Zhonghua Nei Ke Za Zhi. 1981 Nov;20(11):678-83
references.pmid: 7341098
references.citation: BMC Complement Altern Med. 2014 May 07;14:151
references.pmid: 24885561
references.citation: PLoS One. 2013 Jul 24;8(7):e70586
references.pmid: 23894675
references.citation: Medicine (Baltimore). 2015 Jul;94(27):e1111
references.pmid: 26166106
references.citation: Medicine (Baltimore). 2015 Jul;94(27):e1083
references.pmid: 26166088
references.citation: Int J Surg. 2012;10(1):28-55
references.pmid: 22036893
references.citation: Planta Med. 2010 Dec;76(17):2048-64
references.pmid: 20979016
references.citation: PLoS One. 2011 Feb 25;6(2):e16922
references.pmid: 21364920
references.citation: JAMA. 2013 Sep 4;310(9):948-59
references.pmid: 24002281